Unable to load price data. Sorry.

¯\_(ツ)_/¯

Dyax Corp. (NASDAQ:DYAX.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DYAX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

gringo33339 (< 20)
Submitted April 26, 2013

Buying opportunity today for this stock which will benefit greatly if LLY sees success in its Ramu pipeline drug candidate.

majakblue (< 20)
Submitted April 14, 2007

Yeah, yeah, yeah, lets see if any of their candidates get past large scale phase III trials. Lets see if the patients have kidneys and liver left afterwards.

NASDAQ:DYAX.DL VS S&P 500 (SPY)

NASDAQ:DYAX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about DYAX.DL.

No one has written a Pitch for DYAX.DL stock yet. Tell us why you think DYAX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in DYAX.DL.

No players have picked DYAX.DL yet. Tell us why you think DYAX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBofASec 91.57 4/23/2014 Outperform NS $7.10 +440.99% -0.60% +441.58 1/22/2016 @ $38.41 0 Comment
TrackRBCCapMkts 83.98 3/25/2014 Outperform NS $9.24 +315.69% +0.17% +315.52 1/22/2016 @ $38.41 0 Comment
TrackJefferies 76.95 6/4/2010 Outperform NS $2.77 +1,286.64% +71.89% +1,214.75 1/22/2016 @ $38.41 0 Comment
trackthinkequity 88.55 9/10/2009 Outperform NS $3.83 -37.86% +18.06% -55.92 11/5/2010 @ $2.38 0 Comment
TrackNeedham 89.80 7/22/2009 Outperform NS $3.61 -56.51% +38.77% -95.28 3/31/2011 @ $1.57 0 Comment
TrackArgus 84.65 4/9/2009 Underperform NS $2.10 +1,729.05% +118.63% -1,610.42 1/22/2016 @ $38.41 0 Comment
TrackWedbush 88.22 3/27/2009 Outperform NS $2.46 +1,461.38% +127.53% +1,333.85 1/22/2016 @ $38.41 0 Comment
TrackUBS 91.49 7/30/2008 Outperform NS $4.29 +795.34% +46.06% +749.28 1/22/2016 @ $38.41 0 Comment
TrackSusquehanna 87.79 1/11/2008 Outperform NS $3.57 +975.91% +32.61% +943.30 1/22/2016 @ $38.41 0 Comment
TrackCreditSuiss 88.04 10/3/2007 Outperform NS $3.60 +966.94% +21.38% +945.57 1/22/2016 @ $38.41 0 Comment
TrackJimCramer 86.33 4/16/2007 Underperform 3W $5.65 +579.82% +27.26% -552.56 1/22/2016 @ $38.41 0 Comment
TrackMorganJos 66.94 3/15/2007 Outperform NS $3.56 +978.93% +34.34% +944.59 1/22/2016 @ $38.41 0 Comment